Predicate Devices

Reference Devices

Not Found

AI/ML (Artificial Intelligence / Machine Learning)

No
The document describes standard ultrasound imaging modes and post-processing features, with no mention of AI, ML, or related concepts like deep learning or neural networks. The device name includes "AIXPLORER", but the description does not indicate this refers to artificial intelligence capabilities.

Therapeutic

No.
The device is described as an ultrasound imaging system intended for "diagnostic general purpose ultrasound imaging studies" and "fluid flow analysis," without any mention of therapeutic functions.

Diagnostic

Yes

Explanation: The "Device Description" states that the system is used to "perform non-invasive diagnostic general purpose ultrasound imaging studies." Additionally, the "Mentions image processing" section notes that image post-processing features aid in "clinical evaluation and diagnosis."

SaMD (Software as a Medical Device)

No

The device description explicitly states it is a "cart based ultrasound imaging system" and includes hardware components like transducers, a scan converter, a monitor, and a control panel.

IVD (In Vitro Diagnostic)

Based on the provided information, the SuperSonic Imagine AIXPLORER® ultrasound system is not an In Vitro Diagnostic (IVD) device.

Here's why:

Definition of IVD: IVD devices are used to examine specimens (like blood, urine, or tissue) taken from the human body to provide information about a person's health. They perform tests in vitro (outside the body).
Device Description: The description clearly states the AIXPLORER® is a "cart based ultrasound imaging system used to perform non-invasive diagnostic general purpose ultrasound imaging studies." It uses ultrasound waves to create images of internal structures in vivo (inside the body).
Intended Use: The intended use describes imaging and Doppler analysis of the human body, not the analysis of specimens.
Lack of Specimen Handling: There is no mention of the device being used to process or analyze biological specimens.

Therefore, the SuperSonic Imagine AIXPLORER® is a diagnostic imaging device, not an IVD.

PCCP (Predetermined Change Control Plan) Authorized

N/A

Overview

Intended Use / Indications for Use

Intended Use: The SuperSonic Imagine AIXPLORER® ultrasound system and transducer are intended for general purpose pulse echo ultrasound imaging and Doppler fluid flow analysis of the human body. Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Indications for Use: The SuperSonic Imagine AIXPLORER® ultrasound system is indicated for use in the following applications: Abdominal, Small Organs, Musculoskeletal, Superficial Musculoskeletal, Vascular, Peripheral Vascular, GYN, Pelvic, Pediatric, Urology, Trans-rectal and Trans-vaginal.

The system also provides the ability to measure anatomical structures (Abdominal, Small Organs, Musculoskeletal, Superficial Musculoskeletal, Peripheral Vascular, GYN, Pelvic, Pediatic, Urology, Transrectal and Trans-vaginal).

Product codes (comma separated list FDA assigned to the subject device)

90-IYN, 90-IYO, 90-ITX, IYN, ITX

Device Description

The SuperSonic Imagine AIXPLORER® system is a cart based ultrasound imaging system used to perform non-invasive diagnostic general purpose ultrasound imaging studies. The system contains a scan converter and can be coupled to a variety of linear, curved, micro-convex, and motorized linear array transducers to produce images, which are displayed on a LCD monitor. An adjustable control panel with integrated touch screen allows the user to perform an ultrasound exam quickly and efficiently in accordance with ALARA principles. The system also allows the user to perform measurements, capture images to digital memory or to an external device (such as a printer), and review diagnostic studies in the form of a report. The system functions in a manner identical to the predicate devices and transducers for the imaging modes: B-Mode, Color Flow, Pulsed Wave Doppler, Harmonic Imaging, Amplitude Dopler, 3D imaging and for ShearWave™ elastography.

Mentions image processing

The systems have similar capability in terms of harmonic imaging, spatial compound imaging, elastography imaging and other image post-processing features to improve the image quality and aid in clinical evaluation and diagnosis.

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Ultrasound

Anatomical Site

Abdominal, Small Organs, Musculoskeletal, Superficial Musculoskeletal, Vascular, Peripheral Vascular, GYN, Pelvic, Pediatric, Urology, Trans-rectal, Trans-vaginal, Breast, Thyroid, Testicle, Prostate, Penis

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The documentation provided demonstrates that:

The system and transducers are substantially equivalent to the predicate devices.
There are no new questions of safety and effectiveness concerning the SuperSonic Imagine AIXPLORER® ultrasound system and transducers.
The ultrasound device has been scientifically evaluated and has been demonstrated to be at least as safe and effective as the predicate devices cited in item 3. The system's acoustic power levels are below the applicable FDA limits.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

AIXPLORER® Ultrasound Imaging System (K091970), Siemens Acuson S2000TM Diagnostic Ultrasound System (K072786), Philips iU22 Ultrasound System (K093563)

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

Regulation Number and Section

§ 892.1570 Diagnostic ultrasonic transducer.

(a)
Identification. A diagnostic ultrasonic transducer is a device made of a piezoelectric material that converts electrical signals into acoustic signals and acoustic signals into electrical signals and intended for use in diagnostic ultrasonic medical devices. Accessories of this generic type of device may include transmission media for acoustically coupling the transducer to the body surface, such as acoustic gel, paste, or a flexible fluid container.(b)
Classification. Class II.

Summary

0

510(k) Summary of Safety and Effectiveness

This summary of safety and effectiveness information is submitted in accordance with 21 CFR §807.92.

1) Submitter's name, address, telephone number, contact person

. Submitted by: SuperSonic Imagine, S.A. Les Jardins de la Duranne – Bât. E & F 510, rue René Descartes 13857 Aix-en-Provence Cedex France Telephone: 011 33 442 99 24 24

K102041

OCT 1 3 2010

Distributed by: SuperSonic Imagine, Inc. 11714 North Creek Parkway N Suite 150 Bothell, WA 98011 North America Telephone: +1(425) 686 6380

*** Corresponding Official:

Jacques Souquet Chief Executive Officer Telephone: 011 33 442 99 24 35

Date: 2010/07/13

2) Name of the device, including the trade or proprietary name if applicable, the common or usual name, and the classification name, if known:

Common/Usual Name: Diagnostic Ultrasound System with Accessories Proprietary Name: Aixplorer®

Classification:

Regulatory Class: II

Classification Name:	21 CFR Section	Product Code
Ultrasonic Pulsed Doppler Imaging System	892.1550	90-IYN
Ultrasonic Pulsed Echo Imaging System	892.1560	90-IYO
Diagnostic Ultrasound Transducer	892.1570	90-ITX

3) Substantially Equivalent/Predicate Devices

AIXPLORER® Ultrasound Imaging System (K091970), cleared on 08/12/2009 Siemens Acuson S2000TM Diagnostic Ultrasound System (K072786), cleared on 11/13/2007 Philips iU22 Ultrasound System (K093563), cleared on 02/01/2010

1

4) Description of Device

The SuperSonic Imagine AIXPLORER® system is a cart based ultrasound imaging system used to perform non-invasive diagnostic general purpose ultrasound imaging studies. The system contains a scan converter and can be coupled to a variety of linear, curved, micro-convex, and motorized linear array transducers to produce images, which are displayed on a LCD monitor. An adjustable control panel with integrated touch screen allows the user to perform an ultrasound exam quickly and efficiently in accordance with ALARA principles. The system also allows the user to perform measurements, capture images to digital memory or to an external device (such as a printer), and review diagnostic studies in the form of a report. The system functions in a manner identical to the predicate devices and transducers for the imaging modes: B-Mode, Color Flow, Pulsed Wave Doppler, Harmonic Imaging, Amplitude Dopler, 3D imaging and for ShearWave™ elastography.

5) Intended Use

The SuperSonic Imagine AIXPLORER® ultrasound system and transducer are intended for general purpose pulse echo ultrasound imaging and Doppler fluid flow analysis of the human body.

6) Indication for Use

The SuperSonic Imagine AIXPLORER® ultrasound system is indicated for use in the following applications: Abdominal, Small Organs, Musculoskeletal, Superficial Musculoskeletal, Vascular, Peripheral Vascular, GYN, Pelvic, Pediatric, Urology, Trans-rectal and Trans-vaginal.

The system also provides the ability to measure anatomical structures (Abdominal, Small Organs, Musculoskeletal, Superficial Musculoskeletal, Peripheral Vascular, GYN, Pelvic, Pediatic, Urology, Transrectal and Trans-vaginal).

7) Safety Considerations

As a Track 3 ultrasound device, the SuperSonic Imagine AIXPLORER® ultrasound system is designed to comply with the "Standard For Real Time Display Of Thermal And Mechanical Acoustic Output Indices On Diagnostic Ultrasound Equipment" AIUM/NEMA 2004a published by the National Electrical Manufacturers Association as UD -3. With respect to limits on acoustic outputs, the SuperSonic Imagine AIXPLORER® ultrasound system complies with the FDA guideline limits set in the September 9, 2008, 510(k) diagnostic ultrasound guidance.

With regard to general safety, the SuperSonic Imagine AIXPLORER® ultrasound system scanner is designed to comply with IEC 60101 - 1 (2005) Medical Electrical Equipment, Part 1: General Requirements for Basic Safety and Essential Performance, and IEC 60601 - 2-37 (2007): Particular Requirements For The Safety Of Ultrasonic Medical Diagnostic And Monitoring Equipment.

Mechanical Index	1.9 (Maximum)
TIS/TIB	0.1 - 4.0 (Range)
ISPTA (d)	720 mW/cm2
ISPPA (d)	0 - 700 W/cm2

The device's acoustic output limits are:

The limits are the same as predicate Track 3 devices. These considerations apply to all modes the system offers.

8) Comparison to Predicate Devices

The SuperSonic Imagine AIXPLORER® system and transducers are substantially equivalent to the predicate devices with regard to intended use, imaging capabilities, safety and effectiveness.

The systems are all intended for diagnostic ultrasound imaging and fluid flow analysis. .
- The systems have the same clinical indications for use. .

2

. The systems have the same B-Mode (grayscale imaging) and Doppler capabilities.
. The systems have similar capability in terms of harmonic imaging, spatial compound imaging, elastography imaging and other image post-processing features to improve the image quality and aid in clinical evaluation and diagnosis.
. The transducers are similar in materials, manufacture and clinical capability.
The systems are manufactured with materials which have been evaluated and found to be safe . for the intended use of the device.
. The systems have acoustic power levels which are below the applicable FDA limits.
The systems have similar capability in terms of performing measurements, capturing digital . images, reviewing and reporting studies.
The systems have been found to be manufactured in compliance with approved electrical and . physical safety standards.

9) Conclusion

The documentation provided demonstrates that:

1. The system and transducers are substantially equivalent to the predicate devices.
1. There are no new questions of safety and effectiveness concerning the SuperSonic Imagine AIXPLORER® ultrasound system and transducers.
1. The ultrasound device has been scientifically evaluated and has been demonstrated to be at least as safe and effective as the predicate devices cited in item 3. The system's acoustic power levels are below the applicable FDA limits.

3

Image /page/3/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes forming its wing and tail. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the eagle.

Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002

Mr. Jacques Souquet CEO SuperSonis Imaging Les Jardins de la Duranne-bât. E & F, 510 rue René Descartes Aix-en-Provence, 13857 FRANCE

Re: K102041

Trade/Device Name: AIXPLORER® Ultrasound System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: II Product Code: IYN, ITX, and IYN Dated: July 13, 2010 Received: July 19, 2010

Dear Mr. Souquet:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

This determination of substantial equivalence applies to the following transducers intended for use with the AIXPLORER® Ultrasound System, as described in your premarket notification:

Transducer Model Number

SL15-4 Transducer (1D Linear Array) SC6-1 Transducer (Curved Array) SE12-3 Transducer (Endocavity) SLV16-5 Tranducer (Motorized Linear)

4

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803). please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

If you have any questions regarding the content of this letter, please contact Paul Hardy at (301) 796-6542.

Sincerely yours,

David G. Brown, Ph.D. . . Acting Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health

Enclosure(s)

5

510(k) number (if known):

Device Name: AIXPLORER® Ultrasound System

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Indications for Use:

The SuperSonic Imagine AIXPLORER® ultrasound system is indicated for use in the following applications: Abdominal, Small Organs, Musculoskeletal, Superficial Musculoskeletal, Vascular, Peripheral Vascular, GYN, Pelvic, Pedialric, Urology, Trans-rectal and Trans-vaginal.

The system also provides the ability to measure anatomical structures (Abdominal, Small Organs, Musculoskeletal, Superficial Musculoskeletal, Peripheral Vascular, GYN, Pelvic, Pediatric, Urology, Transrectal and Trans-vaginal).

Prescription Use _ XX

(Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE) Page 1 of 11

(Division Sign-Off)

Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety

510K K162041

6

	Clinical Application		Mode of Operation
General
(Track 1 Only)	Specific
(Tracks 1 & 3)	B	MPWD	CWD	Color
Doppler	Combined
(Specify)	Other*
(Specify)
Ophthalmic	Ophthalmic
Fetal Imaging
& Other	Fetal
	Abdominal	P	P		P	P 1, 2, 3	P 4, 5, 6, 7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric	N	N		N	N, 1, 2, 3	N 4, 5, 6, 7
	Small Organ (for example Breast,
Thyroid, Testicle, Prostate, Penis)	P	P		P	P, 1, 2, 3	P 4, 5, 6, 7
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal (Conventional)	P	P		P	P, 1, 2, 3	P 4, 5, 6, 7
	Musculo-skeletal (Superficial)	P	P		P	P, 1, 2, 3	P 4, 5, 6, 7
	Intravascular
	GYN
	Pelvic
	Other (Specify)
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Intravascular (Cardiac)
	Trans-esoph. (Cardiac)
	Intra-cardiac
	Other (Specify)
Peripheral
Vessel	Peripheral vessel	P	P		P	P, 1, 2, 3	P 4, 5, 6, 7
	Other (Specify)

N = new indication; P = previously cleared by FDA (K091970).

Additional Comments:

1: Combined modes include: B+ Color Flow

2: Combined modes include: B+ ShearWave
TM Elastography

3: Combined modes Include: B+ Pulsed Wave

4: Harmonic Imaging

5: Spatial Compounding

6: ShearWaveTM Elastography

7: Imaging Guidance for Biopsies

(Division Sign-Off)

Division of Radiological Devices

Office of In Vitro Diagnostic Device Evaluation and Safety

510K: K102041

(Please do Not write Below This LinE-Continue on Another Page IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Page 5 of 11

7

510(k) Number (if known):

Device Name: SC6-1 transducer (curved array transducer)

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application		Mode of Operation
General
(Track 1 Only)	Specific
(Tracks 1 & 3)	B M PWD CWD	Color
Doppler	Combined
(Specify)	Other*
(Specify)
Ophthalmic	Ophthalmic
Fetal Imaging
& Other	Fetal
& Other	Abdominal (including urolology)	N N	N	N, 1, 2, 3	N, 4, 5, 6,
7, 8
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric	N N	N	N, 1, 2, 3	N, 4, 5, 6, 7
	Small Organ (Breast, Thyroid,
Testicle, Prostate, penis, etc...)	N N	N	N, 1, 2, 3	N, 4, 5, 6, 7
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal (Conventional)	N N	N	N, 1, 2, 3	N, 4, 5, 6, 7
	Musculo-skeletal (Superficial)	N N	N	N. 1, 2, 3	N, 4, 5, 6, 7
	Intravascular
	GYN	N N	N	N. 1. 2. 3	N. 4, 5, 6, 7
	Pelvic	N N	N	N, 1, 2, 3	N, 4, 5, 6, 7
	Other (Specify)
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Intravascular (Cardiac)
	Trans-esoph. (Cardiac)
	Intra-cardiac
	Other (Specify)
Peripheral
Vessel	Peripheral vessel	N N	N	N, 1, 2, 3	N, 4, 5, 6, 7
Vessel	Other (Specify)	N N	N	N. 1. 2. 3	N. 4, 5, 6, 7

N = new indication; P = previously cleared by FDA (K091970)

Additional Comments:

1: Cambined modes include: B+ Color Flow

2: Combined modes include: B+ ShearWave™ Elastography

3: Combined modes include: 8+ Pulsed Wave

. .

4: Harnonic Imaging

5: Spatial Compounding

5: Spallal Compounding
6: ShearWave 14 Elaslography

7: Imaging Guidance for Blopsies

8: Contrasi mode

(Division Sign-Off)

Division of Hadiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety

510K

Prescription Use XX OR Over-The-Counter Use _

(Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

8

510(k) Number (if known): . .

Device Name: SE12-3 transducer (endocavitary Iransducer)

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application			Mode of Operation
General
(Track 1 Only)	Specific
(Tracks 1 & 3)		B	M	P	WD	CWD	Color
Doppler	Combined
(Specify)	Other*
(Specify)
Ophthalmic	Ophthalmic
Fetal Imaging
& Other	Fetal
	Abdominal
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ (for example Breast,
Thyroid, Testicle, Prostate, penis,
etc...)		N		N			N	N, 1, 2, 3	N, 4, 5, 6,
7
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal		N		N			N	N, 1, 2, 3	N, 4, 5, 6, 7
	Trans-vaginal		N		N			N	N, 1, 2, 3	N, 4, 5, 6, 7
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal (Conventional)
	Musculo-skeletal (Superficial)
	Intravascular
	GYN		N		N			N	N, 1, 2, 3	N, 4, 5, 6, 7
	Pelvic		N		N			N	N, 1, 2, 3	N, 4, 5, 6, 7
	Other (Specify)
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Intravascular (Cardiac)
	Trans-esoph. (Cardiac)
	Intra-cardiac
	Other (Specify)
Peripheral
Vessel	Peripheral vessel		N		N			N	N, 1, 2, 3	N, 4, 5, 6,
7
	Other (Specify)

N = new indication; P = previously cleared by FDA (K091970)

Additional Comments:

1; Combined modes include: 8+ Color Flow
2: Combined modes include: B+ ShearWave™ Elastography

3: Combined modes include: B+ Pulsed Wave

Hamonic Imaging

5: Spatial Compounding

1. Spatial Compounding
  6: ShearWave™ Elastography
  7: Imaging Guidance for Biopsies

. .

(Division Sign-Off)

Division of Radiological Devices

Office of In Vitro Diagnostic Device Evaluation and Safety

K162041
510K

510K. 1516204

OR Over-The-Counter Use Prescription Use XX

(Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)

{PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Page 9 of 11

9

510(k) Number (if known):

Device Name: SLV16-5 transducer (molorized linear transducer) Intended Use: Di

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

	Clinical Application				Mode of Operation
General
(Track 1 Only)	Specific
(Tracks 1 & 3)		B	MPWD	CWD	Color
Doppler	Combined
(Specify)	Other
(Specify)
Ophthalmic	Ophthalmic
Fetal Imaging
& Other	Fetal
	Abdominal		N	N	N		N, 1, 2, 3	N 4, 5, 6,
7, 9
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric		N	N	N		N, 1, 2, 3	N 4, 5, 6,
7, 9
	Small Organ (for example Breast,
Thyroid, Testicle, Prostate, penis,
etc...)		N	N	N		N. 1, 2, 3	N 4, 5, 6,

9 |
| | Neonatal Cephalic | | | | | | | |
| | Adult Cephalic | | | | | | | |
| | Trans-rectal | | | | | | | |
| | Trans-vaginal | | | | | | | |
| | Trans-urethral | | | | | | | |
| | Trans-esoph. (non-Card.) | | | | | | | |
| | Musculo-skeletal (Conventional) | | N | N | N | | N. 1, 2, 3 | N 4. 5, 6.
9 |
| | Musculo-skeletal (Superficial) | | N | N | N | | N, 1, 2, 3 | N 4, 5, 6,
9 |
| | Intravascular | | | | | | | |
| | GYN | | | | | | | |
| | Pelvic | | | | | | | |
| | Other (Specify) | | | | | | | |
| Cardiac | Cardiac Adult | | | | | | | |
| | Cardiac Pediatric | | | | | | | |
| | Intravascular (Cardiac) | | | | | | | |
| | Trans-esoph. (Cardiac) | | | | | | | |
| | Intra-cardiac | | | | | | | |
| | Other (Specify) | | | | | | | |
| Peripheral | Peripheral vessel | | N | N | N | | N, 1, 2, 3 | N 4, 5. 6,
7,9 |
| Vessel | Other (Specify) | | | | | | | |
| | N = new indication; P = previously cleared by FDA (K091970) | | | | | | | |
| Additional Comments:
4: Harmonic Imaging
5: Spatial Compounding
6: ShearWave " Elastography | 1: Combined modes include: B+ Color Flow
2: Combined modes include: B+ ShearWave™ Elastography
3: Combined modes include: B+ Pulsed Wave | | | | | (Division Sign-Off)
Division of Radiological Devices | Office of In Vitro Diagnostic Device Evaluation and Safety | |
| 7: Imaging Guidance for Biopsies
9: 3D imaging | | | | 510K | | | | |
| | Prescription Use
XX | | | | | OR Over-The-Counter Use | | |

(Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE) Page 11 of 11